Intersect ENT's Series C Round

Intersect ENT raised a round of funding on November 03, 2010.

Intersect ENT, formerly Sinexus, is a developer in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for patients with ear, nose and throat cond…

Articles about Intersect ENT's Series C Round: